Related Experiment Video
Updated: Jun 4, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure
Christophe Beauloye1, Luc Bertrand, Sandrine Horman
1Institut de Recherche Expérimentale et Clinique, Pôle de Recherche Cardio-Vasculaire, Université catholique de Louvain, Brussels, Belgium.
Insights
Heart failure involves a chronic energy deficit in the heart. AMP-activated protein kinase (AMPK) may be a therapeutic target, regulating cellular energy and potentially protecting the heart.
Area of Science:
- Cardiology
- Metabolic Disorders
- Molecular Biology
Background:
- Heart failure is characterized by progressive cardiac dysfunction and a chronic energy deficit.
- Metabolic disturbances significantly contribute to the transition from compensated hypertrophy to decompensated heart failure.
- Cellular energy sensing mechanisms, like AMP-activated protein kinase (AMPK), are implicated in heart failure pathogenesis.
Purpose of the Study:
- To review the current understanding of the chronic energy deficit in heart failure.
- To explore the role of AMPK in cellular energy homeostasis and its non-metabolic functions.
- To discuss the potential cardioprotective effects of AMPK in cardiac hypertrophy and heart failure.
Main Methods:
- Literature review of studies on cardiac energy metabolism.
- Analysis of research on AMP-activated protein kinase (AMPK) signaling pathways.
- Synthesis of data regarding AMPK's role in cardiac hypertrophy and heart failure.
Main Results:
- Failing hearts exhibit a significant chronic energy deficit.
- AMPK activation influences cellular metabolism and energy balance.
- AMPK has both energetic and non-metabolic effects relevant to cardiac health.
Conclusions:
- AMPK plays a crucial role in maintaining energy homeostasis within the heart.
- Targeting AMPK may offer a therapeutic strategy for heart failure.
- Further research is needed to elucidate the balance between AMPK's energetic and non-metabolic actions in cardioprotection.
Abstract:
Heart failure is a progressive muscular disorder leading to a deterioration of the heart characterized by a contractile dysfunction and a chronic energy deficit. As a consequence, the failing heart is unable to meet the normal metabolic and energy needs of the body. The transition between compensated left ventricular hypertrophy and the de-compensated heart is multifactorial, although metabolic disturbances are considered to play a significant role. In this respect, the AMP-activated protein kinase (AMPK) could be a potential target in heart failure development. AMPK senses the energy state of the cell and orchestrates a global metabolic response to energy deprivation. We briefly review here the current knowledge about the chronic energy deficit of the failing heart, as well as the role of AMPK in energy homeostasis and in the control of non-metabolic targets in relation to cardiac hypertrophy and heart failure. The relative importance of energetic and non-metabolic effects in the potential cardioprotective action of AMPK is discussed.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
PI3K/mTOR/AKT Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

